114 related articles for article (PubMed ID: 10451879)
1. Radionuclide therapy in the United Kingdom in 1995.
Clarke SE; Clarke DG; Prescod N
Nucl Med Commun; 1999 Aug; 20(8):711-7. PubMed ID: 10451879
[TBL] [Abstract][Full Text] [Related]
2. Survey of attitudes of UK clinical oncologists towards radionuclide therapy.
Rowell NP
Clin Oncol (R Coll Radiol); 1999; 11(4):232-9. PubMed ID: 10473719
[TBL] [Abstract][Full Text] [Related]
3. Re-audit of radiotherapy waiting times 2003.
Ash D; Barrett A; Hinks A; Squire C;
Clin Oncol (R Coll Radiol); 2004 Sep; 16(6):387-94. PubMed ID: 15487130
[TBL] [Abstract][Full Text] [Related]
4. Systemic radionuclide therapy in pain palliation.
Liepe K; Runge R; Kotzerke J
Am J Hosp Palliat Care; 2005; 22(6):457-64. PubMed ID: 16323716
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic radionuclides in nuclear medicine: current and future prospects.
Yeong CH; Cheng MH; Ng KH
J Zhejiang Univ Sci B; 2014 Oct; 15(10):845-63. PubMed ID: 25294374
[TBL] [Abstract][Full Text] [Related]
6. Nuclear medicine activity in the United Kingdom.
Wall BF; Hillier MC; Kendall GM; Shields RA
Br J Radiol; 1985 Feb; 58(686):125-30. PubMed ID: 4063649
[TBL] [Abstract][Full Text] [Related]
7. Use of therapeutic radionuclides in medicine.
Early PJ; Landa ER
Health Phys; 1995 Nov; 69(5):677-94. PubMed ID: 7558861
[TBL] [Abstract][Full Text] [Related]
8. Current and Future Challenges of Radiation Oncology in Iran: A Report from the Iranian Society of Clinical Oncology.
Ameri A; Barzegartahamtan M; Ghavamnasiri M; Mohammadpour R; Dehghan H; Sebzari A; Novin K; Aloosh M
Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):262-268. PubMed ID: 29338969
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide therapy.
Buchanan RB; Lewington VJ
Nucl Med Commun; 1999 Aug; 20(8):687. PubMed ID: 10451875
[No Abstract] [Full Text] [Related]
10. Clinical trials in molecular radiotherapy-Tribulations and Triumphs Report of the NCRI CTRad meeting held at the Lift Islington, 8 June 2018.
Falzone N; Gregory R; Aldridge M; Terry SY; Flux G
Br J Radiol; 2019 Aug; 92(1100):20190117. PubMed ID: 30982344
[TBL] [Abstract][Full Text] [Related]
11. The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I/123I-MIBG as predictors for radionuclide therapy.
Gao Z; Biersack HJ; Ezziddin S; Logvinski T; An R
J Cancer Res Clin Oncol; 2004 Nov; 130(11):649-56. PubMed ID: 15300425
[TBL] [Abstract][Full Text] [Related]
12. [Use of radionuclides in therapy].
Vucina J; Han R
Med Pregl; 2001; 54(5-6):245-50. PubMed ID: 11759220
[TBL] [Abstract][Full Text] [Related]
13. Nurse endoscopists in United Kingdom health care: a survey of prevalence, skills and attitudes.
Pathmakanthan S; Murray I; Smith K; Heeley R; Donnelly M
J Adv Nurs; 2001 Dec; 36(5):705-10. PubMed ID: 11737503
[TBL] [Abstract][Full Text] [Related]
14. Options for radionuclide therapy: from fixed activity to patient-specific treatment planning.
Thomas SR
Cancer Biother Radiopharm; 2002 Feb; 17(1):71-82. PubMed ID: 11915175
[TBL] [Abstract][Full Text] [Related]
15. Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists.
Chow E; Danjoux C; Wong R; Szumacher E; Franssen E; Fung K; Finkelstein J; Andersson L; Connolly R
Radiother Oncol; 2000 Sep; 56(3):305-14. PubMed ID: 10974379
[TBL] [Abstract][Full Text] [Related]
16. Radionuclide therapy revisited.
Hoefnagel CA
Eur J Nucl Med; 1991; 18(6):408-31. PubMed ID: 1879447
[TBL] [Abstract][Full Text] [Related]
17. Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran.
Jalilian AR; Beiki D; Hassanzadeh-Rad A; Eftekhari A; Geramifar P; Eftekhari M
Semin Nucl Med; 2016 Jul; 46(4):340-58. PubMed ID: 27237443
[TBL] [Abstract][Full Text] [Related]
18. Clinical applications of newer radionuclide therapies.
Brans B; Linden O; Giammarile F; Tennvall J; Punt C
Eur J Cancer; 2006 May; 42(8):994-1003. PubMed ID: 16564689
[TBL] [Abstract][Full Text] [Related]
19. Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases.
Palmedo H; Guhlke S; Bender H; Sartor J; Schoeneich G; Risse J; Grünwald F; Knapp FF; Biersack HJ
Eur J Nucl Med; 2000 Feb; 27(2):123-30. PubMed ID: 10755716
[TBL] [Abstract][Full Text] [Related]
20. [Draft guideline regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors Drafting Committee for Guideline of Radiotherapy with 131I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine].
Kinuya S; Yoshinaga K; Higuchi T; Jinguji M; Kawamoto H; Kurihara H
Kaku Igaku; 2015 Feb; 52(1):1-15. PubMed ID: 26502667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
